Given the rapidly evolving regulatory landscape coupled with increasing regulatory requirements, it is important to understand how best to approach regulatory hurdles during product development and registration. As much as the approval of drug product(s) is critical for any business, “robust” regulatory strategies are critical to preventing NDA review issues, complete responses, and consequent approval delays.